Wexner Medical Center employees speak to burnout in the workplace in light of receiving Joy in Medicine award thelantern.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelantern.com Daily Mail and Mail on Sunday newspapers.
UCI receives $4.2 million grant to study sporadic inclusion body myositis affecting aging adults
The National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded UCI a 5-year, $4.2 million grant to study sporadic inclusion body myositis (sIBM), which affects aging adults causing asymmetric muscle weakness and severe disability. The disease is currently untreatable and poorly understood.
Led by principal investigator, Tahseen Mozaffar, MD, a professor of neurology and director of the Division of Neuromuscular Disorders and the UCI-MDA ALS and Neuromuscular Center at University of California Irvine s School of Medicine, the project aims to provide a detailed characterization of sIBM disease progression over a two-year period and explore biomarkers associated with the disease, along with their influence on disease behavior and progression. This study will be the largest of its kind, enrolling 150 subjects, with a planned two-year follow up, the longest duration to
E-Mail
IMAGE: Tahseen Mozaffar, MD, a professor of neurology and director of the Division of Neuromuscular Disorders and the UCI-MDA ALS and Neuromuscular Center at UCI s School of Medicine will lead a. view more
Credit: UCI School of Medicine
Irvine, CA - April 6, 2021 - The National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded UCI a 5-year, $4.2 million grant to study sporadic inclusion body myositis (sIBM), which affects aging adults causing asymmetric muscle weakness and severe disability. The disease is currently untreatable and poorly understood.
Led by principal investigator, Tahseen Mozaffar, MD, a professor of neurology and director of the Division of Neuromuscular Disorders and the UCI-MDA ALS and Neuromuscular Center at University of California Irvine s School of Medicine, the project aims to provide a detailed characterization of sIBM disease progression over a two-year period and explore biomarkers associated with the disease,